MedWatch

Novo Nordisk grants Taiwanese firm access to smart pen data

A new collaboration between Novo Nordisk and Health2Synch enables users of the latter company’s app solution to automatically register data about their insulin treatments when using Novo’s smart injector pens.

Photo: Novo Nordisk / PR

Novo Nordisk’s smart insulin pens, Novopen 6 and Novopen Echo Plus, will be able to transfer insulin dose logs directly to app Health2Synch in the future, says the app’s developer going by the same name in a press release.

The partnership is the latest in a string of similar deals for Novo Nordisk, which includes firms like Dexcom, Glooko and Roche, all aiming to make it easier for diabetes patients to track when and how many insulin doses are injected.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs